Skip to main content
. 2016 Mar 1;24(2):171–177. doi: 10.4062/biomolther.2015.089

Table 1.

Effect of CoQ10 supplementation on liver and heart weight in the Statin-treated obese rats

Group Liver Heart

Total Relative Total Relative
N 9.58 ± 0.22## 2.21 ± 0.02 1.32 ± 0.02###$$ 0.30 ± 0.00
NSC270 9.54 ± 0.29## 2.29 ± 0.03 1.26 ± 0.02###$$$ 0.30 ± 0.00
H 11.00 ± 0.56** 2.30 ± 0.08 1.51 ± 0.02***$ 0.32 ± 0.00$
HS 10.42 ± 0.22 2.20 ± 0.04 1.42 ± 0.03**# 0.30 ± 0.01#
HC 9.62 ± 0.11## 2.07 ± 0.03# 1.42 ± 0.03**# 0.31 ± 0.01
HSC30 10.43 ± 0.18 2.26 ± 0.03 1.44 ± 0.01*** 0.31 ± 0.00
HSC90 10.07 ± 0.26 2.18 ± 0.04 1.42 ± 0.01*# 0.31 ± 0.00
HSC270 9.55 ± 0.25## 2.19 ± 0.05 1.34 ± 0.03### 0.31 ± 0.01

Values are means ± S.E. (n=10).

*

p<0.05,

**

p<0.01,

***

p<0.001 vs. normal diet group,

#

p<0.05,

##

p<0.01,

###

p<0.001 vs. high-fat diet group,

$

p<0.05,

$$

p<0.01,

$$$

p<0.001 vs. high-fat diet with Statin group. N: normal diet group, NSC270: normal diet with Statin and CoQ10 (270 mg/kg) group, H: high-fat diet group, HS: high-fat diet with Statin group, HC: high-fat diet with CoQ10 (270 mg/kg) group, and HSC30, HSC90, HSC270: high-fat diet with Statin and CoQ10 at various doses (30, 90 or 270 mg/kg) group.